AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
A practical introduction to Zero Based Budgeting, outlining why it works and how to start implementing it in your finances. Learn steps, tools, and best practices to optimize every dollar.
17,218 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
A seasoned travel-points expert fell for a fake invitation, and thieves turned 330,000 miles into gift cards. This gu...
A high-net-worth retiree in washington discovers that a single Social Security claiming choice could cut his lifetime...
A private AI platform reports 1.5 million users and opens a new round at sub-$1, inviting retail investors. The compa...
A space-focused Nasdaq-100 entrant is drawing attention after earnings and a key index promotion. Investors see a pot...
As of June 22, 2026, Vanguard’s international dividend ETF is delivering a higher yield and stronger year-to-date per...
Allium, a crypto analytics startup, secures a $40 million Series B to scale its data platform for institutional clien...
A new analysis shows Microsoft’s AI-driven revenue pace hitting fresh highs, suggesting meaningful upside for patient...
Stocks wobbled as a memory-chip selloff led by South Korea dragged down Micron and peers. This article breaks down wh...
A former chief staff mayor to NYC Mayor Eric Adams has been arrested on bribery and fraud charges, part of a widening...
Nokia’s latest move isn't about handsets—it's about AI-friendly data-center networks. The Nokia acquired Infinera qui...
SpaceX has experienced a sharp move after going public, sparking questions about lockups and what it means for future...